Table 5. Diagnostic Performance of Serum YB-1, AFP and YB-1+AFP for HCC.
Tumor Marker | Cut-Off Value, μg/L | HCC Patients | Controls, HBV + HBV Cirrhosis + Healthy | Sensitivity, %a | Specificity, %b | Accuracy, %c | ||
---|---|---|---|---|---|---|---|---|
Cases | Positive | Cases | Positive | |||||
YB-1d | 16.0 | 105 | 80 | 100 | 37 | 74.1 | 63.0 | 69.8 |
AFP | 414 | 105 | 47 | 100 | 7 | 44.8 | 93.0 | 68.3 |
YB-1+AFP | ibid | 105 | 94 | 100 | 38 | 89.5 | 62.0 | 76.1 |
aSensitivity = TP/(TP + FN), where TP = true positive, FN = false negative
bSpecificity = TN/(TN + FP), where TN = true negative, FP = false positive
cAccuracy = (TP + TN)/(TP + FP + TN + FN)
dAbbreviations: AFP, alpha-fetoprotein; HCC, hepatocellular carcinoma